{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:48:57Z","timestamp":1782233337124,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ntt.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T08:15:49Z","timestamp":1502698549000},"page":"9-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The pharmacokinetic profile of synthetic cathinones in a pregnancy model"],"prefix":"10.1016","volume":"63","author":[{"given":"Lauren G.","family":"Strange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"Kochelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Keasling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks B.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ntt.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/7854_2016_21","article-title":"Neurotoxicology of synthetic cathinone analogs","volume":"32","author":"Angoa-Perez","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.ntt.2017.08.001_bb0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00204-014-1278-7","article-title":"Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones","volume":"89","author":"Araujo","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.ntt.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1038\/npp.2016.40","article-title":"The psychoactive designer drug and bath salt constituent MDPV causes widespread disruption of brain functional connectivity","volume":"41","author":"Colon-Perez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ntt.2017.08.001_bb0020","first-page":"65371","article-title":"Schedules of controlled substances: temporary placement of three synthetic cathinones in schedule I. Final order","volume":"76","author":"DEA","year":"2011","journal-title":"Fed. Regist."},{"key":"10.1016\/j.ntt.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2017.04.006","article-title":"Atypical binding at dopamine and serotonin transporters contribute to the discriminative stimulus effects of mephedrone","volume":"119","author":"DeLarge","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ntt.2017.08.001_bb0030","series-title":"Federal Register","article-title":"Drug Enforcement Schedules of controlled substances: temporary placement of three synthetic cathinones into schedule I","volume":"Vol. 76","year":"2011"},{"key":"10.1016\/j.ntt.2017.08.001_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2013.05.024","article-title":"Mephedrone: public health risk, mechanism of action, and behavioral effects","volume":"714","author":"Dybdal-Hargreaves","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ntt.2017.08.001_bb0040","author":"European Drug Report 2015"},{"key":"10.1016\/j.ntt.2017.08.001_bb0045","series-title":"Obstetrics: Normal and Problem Pregnancies","article-title":"Intrapartum fetal evaluation","author":"Garite","year":"2012"},{"key":"10.1016\/j.ntt.2017.08.001_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.lfs.2013.07.023","article-title":"Bath salts and synthetic cathinones: an emerging designer drug phenomenon","volume":"97","author":"German","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.ntt.2017.08.001_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/1751-486X.12123","article-title":"Implications of psychoactive \u2018bath salts\u2019 use during pregnancy","volume":"18","author":"Gray","year":"2014","journal-title":"Nurs. Womens Health"},{"issue":"11","key":"10.1016\/j.ntt.2017.08.001_bb0060","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00213-017-4568-y","article-title":"Glutatmate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)","volume":"234","author":"Hicks","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ntt.2017.08.001_bb0065","series-title":"Monitoring the Future National Survey Results on Drug Use, 1975\u20132016: Overview, Key Findings on Adolescent Drug use","author":"Johnston","year":"2017"},{"issue":"50","key":"10.1016\/j.ntt.2017.08.001_bb0070","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1556\/OH.2011.29259","article-title":"3,4-methylene-dioxy-pyrovalerone (MDPV) epidemic?","volume":"152","author":"Kalapos","year":"2013","journal-title":"Orv. Hetil."},{"issue":"8","key":"10.1016\/j.ntt.2017.08.001_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/00498250600780191","article-title":"Metabolism of the recently encountered designer drug, methylone, in humans and rats","volume":"36","author":"Kamata","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ntt.2017.08.001_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","article-title":"Synthetic cathinones: a new public health problem","volume":"13","author":"Karila","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ntt.2017.08.001_bb0085","series-title":"Primary Care Companion CNS Disorders","article-title":"\u201cBath Salts\u201d \u2013 induced psychosis in a young woman","volume":"15","author":"Khan","year":"2013"},{"key":"10.1016\/j.ntt.2017.08.001_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ntt.2017.08.001_bb0095","author":"MDPV"},{"key":"10.1016\/j.ntt.2017.08.001_bb0100","author":"Mephedrone"},{"key":"10.1016\/j.ntt.2017.08.001_bb0105","author":"Methylone"},{"key":"10.1016\/j.ntt.2017.08.001_bb0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.chroma.2012.09.079","article-title":"Chiral separation of new cathinone- and amphetamine-related designer drugs by gas chromatography\u2013mass spectrometry using trifluoroacetyl-l-prolyl chloride as chiral derivatization reagent","volume":"1269","author":"Mohr","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ntt.2017.08.001_bb0115","author":"National Forensic Laboratory Information System 2015 Midyear Report"},{"key":"10.1016\/j.ntt.2017.08.001_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.disamonth.2014.01.001","article-title":"Emerging drugs of abuse","volume":"60","author":"Nelson","year":"2014","journal-title":"Dis. Mon."},{"issue":"6","key":"10.1016\/j.ntt.2017.08.001_bb0125","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/dmd.112.050880","article-title":"In vitro metabolism and pharmacokinetic studies on methylone","volume":"41","author":"Pedersen","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.ntt.2017.08.001_bb0130","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/dta.1369","article-title":"In vitro metabolism studies on mephedrone and analysis of forensic cases","volume":"5","author":"Pedersen","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.ntt.2017.08.001_bb0135","first-page":"1","article-title":"Quantification of synthetic cathinones in rat brain using HILIC-ESI-MS\/MS","author":"Peters","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ntt.2017.08.001_bb0140","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.forsciint.2014.10.027","article-title":"Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone","volume":"245","author":"Pichini","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.ntt.2017.08.001_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones","volume":"8","author":"Prosser","year":"2012","journal-title":"J. Med. Toxicol."},{"issue":"1","key":"10.1016\/j.ntt.2017.08.001_bb0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2012.06.012","article-title":"Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL\/6J mice: comparison to cocaine","volume":"234","author":"Robinson","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ntt.2017.08.001_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.ntt.2017.08.001_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","article-title":"Designer cathinones \u2013 an emerging class of novel recreational drugs","volume":"231","author":"Zawilska","year":"2013","journal-title":"Forensic Sci. Int."}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036217301010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036217301010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:22:37Z","timestamp":1760210557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036217301010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":32,"alternative-id":["S0892036217301010"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2017.08.001","relation":{},"ISSN":["0892-0362"],"issn-type":[{"value":"0892-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pharmacokinetic profile of synthetic cathinones in a pregnancy model","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}